focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMP.L Regulatory News (AMP)

  • There is currently no data for AMP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising - Replacement

8 Jan 2007 13:08

Amphion Innovations PLC08 January 2007 This replaces the announcement made today at 7am under RNS number 0790P. Amphion Innovations plc Fundraising Monday 8 January 2007 - Amphion Innovations plc, the developer of life scienceand medical technology businesses, announces today that it successfully closed afundraising of £612,500 (before expenses) on 29th December 2006, the shares wereallotted and issued on 3rd January, 2007. Under the terms of the placing, the Company has issued 2,450,000 new ordinaryshares at 25 pence per share ("the Placing Shares"). The net proceeds from the placing will be used to invest in new and identifiedopportunities. Application will be made for the Placing Shares to be admitted to trading onAIM. It is expected that admission will occur at 8am on Friday 12th January2007. The Placing Shares will rank pari passu in all respects with the existingOrdinary Shares which are currently traded on AIM. Following admission thetotal number of shares in issue will be 100,100,224. As part of the Placing Richard Morgan, a director of Amphion, acquired 300,000Ordinary Shares in the Company at the placing price of 25p per Ordinary Share.Richard Morgan is now interested in 16,289,703 Ordinary Shares representingapproximately 16.274 per cent. of the total number of Ordinary Shares in issuefollowing the Placing. In addition, as part of the Placing, Amphion Capital Partners (a related entityand existing shareholder) acquired 1.025m Ordinary Shares in the Company and isnow interested in 8,025,000 Ordinary Shares representing 8.017 per cent. of thetotal number of Ordinary Shares in issue following the Placing. The shares areregistered in the name of Amphion Capital Partners. The partners in AmphionCapital Partners are Richard Morgan, Robert Bertoldi, Richard Mansell-Jones,Anthony Henfrey and Jim Macaleer, all of whom are directors of AmphionInnovations. Amphion Innovations Directors' interest in Amphion Capital Partners: R.James Macaleer 29.8%Richard Morgan 13.66%Robert Bertoldi 8.54%Richard Mansell-Jones 2.03%Anthony Henfrey 1.32% Total 55.35% For further information please contact: Amphion Innovations plcJosh Berkman, Media Relations +1 (646) 747 7158 Financial Dynamics +44 207 269 7169Ben AtwellJohn Gilbert About Amphion Innovations plc Amphion Innovations plc is listed on the AIM Exchange in London under the symbolAMP. Amphion's business is the formation, financing, management and developmentof life sciences and technology companies, primarily in the US and UK, workingin partnership with corporations, governments, universities and entrepreneursseeking to commercialize their intellectual property. On the web: www.amphionplc.com This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
1st Jul 20155:07 pmRNSHolding(s) in Company
23rd Jun 20158:47 amRNSPartner Company raises £22 million
23rd Jun 20157:00 amRNSPreliminary Results
5th Jun 20157:00 amRNSPlacing to raise £1.54 million
19th May 20152:35 pmRNSAppointment of broker
15th Apr 20157:01 amRNSFDA Results
7th Apr 20157:00 amRNSShares Issued for Exercised Warrants
2nd Apr 20157:01 amRNSFirst Day of Dealings of Amphion Partner Company
24th Mar 20153:28 pmRNSIssue of Shares
20th Mar 20157:01 amRNSMotif Bio Ltd Update Re Intention to Float
26th Feb 20157:00 amRNSIssue of Equity
9th Feb 20157:00 amRNSDirector/PDMR Shareholding
2nd Feb 20154:18 pmRNSReissue: Partner Company's Intention to Float
2nd Feb 20158:00 amRNSPartner Company's Intention to Float on AIM
22nd Jan 20151:15 pmRNSDirector/PDMR Shareholding
19th Jan 20157:00 amRNSLandmark Acquisition & Update by Partner Company
6th Jan 20157:00 amRNSDataTern Receives Favourable Appeal Ruling
24th Sep 20147:00 amRNSDirectors' Dealings
19th Sep 20147:00 amRNSHalf Yearly Report
9th Sep 20147:00 amRNSAdditional Draws on Loan Facility
28th Aug 20147:00 amRNSDirectorate Change
7th Aug 20144:51 pmRNSResult of AGM and EGM
10th Jul 20149:10 amRNSDirectors' Dealings
8th Jul 20147:00 amRNSAmphion Partner Motif Can Help Solve Health Crisis
20th Jun 20147:00 amRNSNotice of EGM
18th Jun 20147:00 amRNSFinal Results
5th Jun 20147:00 amRNSNew Loan Facility
14th Apr 20147:00 amRNSAppeal Ruling
7th Apr 20145:03 pmRNSDirector/PDMR Shareholding
28th Jan 20147:00 amRNSConvertible Promissory Note Extension
12th Dec 20137:00 amRNSUpdate on Covertible Promissory Note
13th Nov 20134:33 pmRNSDirector/PDMR Shareholding
13th Nov 20137:00 amRNSPartner Company Update
16th Oct 20137:02 amRNSPartner Company IPO
24th Sep 20137:00 amRNSHalf Yearly Report
12th Sep 20137:02 amRNSPartner company Kromek seeks IPO on AIM
13th Aug 20135:16 pmRNSResult of AGM
1st Jul 201312:02 pmRNSDirector/PDMR Shareholding
28th Jun 20137:00 amRNSFinal Results
18th Apr 20137:00 amRNSDirector/PDMR Shareholding
17th Apr 20137:00 amRNSTrading Statement
28th Mar 20137:02 amRNSChange of Adviser
19th Dec 20127:00 amRNSHolding(s) in Company
13th Dec 20127:00 amRNSFundraising
5th Dec 20127:00 amRNSAmphion announces new partnership with Motif
3rd Oct 20127:00 amRNSDirector/PDMR Shareholding
28th Sep 20124:24 pmRNSDirector/PDMR Shareholding
19th Sep 20127:00 amRNSHalf Yearly Report
29th Aug 20127:00 amRNSUpdate - patent litigation
27th Jul 20127:00 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.